Dwi Wahyu Indrawati1,2
,
Ernie Maduratna Setiawatie3,
Retno Pudji Rahayu4,
Rini Devijanti Ridwan5,
Hendrik Setia Budi5,
Coen Pramono6,
Ida Bagus Narmada7,8,
Anita Yuliati9,
Devi Rianti10,
Hari Basuki Notobroto11,
Rizky Briliant Syah Manurung12,
Vania Surya Riyadi13
For correspondence:- Dwi Indrawati Email: indrawatidwi55@gmail.com
Received: 9 September 2025 Accepted: 18 April 2026 Published: 30 April 2026
Citation: Indrawati DW, Setiawatie EM, Rahayu RP, Ridwan RD, Budi HS, Pramono C, et al. Development of a hyaluronic acid – bovine pericardium composite membrane for biocompatible biomedical use. Trop J Pharm Res 2026; 25(4):445-452 doi: https://dx.doi.org/10.4314/tjpr.v25i4.1
© 2026 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Purpose: To evaluate the effect of different molecular weights and concentrations of bovine pericardium membranes (BPM) - hyaluronic acid (HA) complex on Baby Hamster Kidney-21 (BHK-21) cells' viability and cytotoxicity. Methods: Bovine pericardium membranes-HA complex were divided into seven groups, namely Group A (1300 kDa HA, 0.5 %), Group B (1300 kDa HA, 1.0 %), Group C (1300 kDa HA, 2.0 %), Group D (120 kDa HA, 0.5 %), Group E (120 kDa HA, 1.0 %), Group F (120 kDa HA, 2.0 %), and Group G (unmodified BPM). Baby hamster kidney fibroblast cells (BHK-21 cells) were exposed for 24 h. Cell viability was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT assay), and cytotoxicity was observed morphologically. Data were analyzed using one-way ANOVA with a significance level set at p < 0.05. Results: The 1.0 % 1300 kDa HA group achieved the highest cell viability (96.70 %), which was significantly higher compared to other treatment groups (p < 0.000). Both molecular weights peaked at 1.0 % with slight decreases at 2.0 %, indicating a threshold effect. The unmodified bovine pericardium membrane had the lowest viability (82.84 %), with significant differences (p = 0.000). Conclusion: Incorporating 1.0 % high-molecular-weight BPM-HA enhances the biocompatibility of bovine pericardium membranes, supporting application in regenerative biomaterials.